When will the pandemic end? It’s the question hanging over just about everything since COVID-19 took over the world last year. The answer can be measured in vaccinations.
Bloomberg has built the biggest database of COVID-19 shots given around the world, with more than 108 million doses administered worldwide. U.S. science officials such as Anthony Fauci have suggested it will take 70% to 85% coverage of the population for things to return to normal. Bloomberg’s Vaccine Tracker shows that some countries are making far more rapid progress than others, using 75% coverage with a two-dose vaccine as a target.
Israel, the country with the highest vaccination rate in the world, is headed for 75% coverage in just two months. The U.S. will get there just in time to ring in 2022 (though North Dakota could get there six months sooner than Texas). With vaccinations happening more rapidly in richer Western countries than the rest of the globe, it will take the world as a whole 7.4 years at the current pace.
Bloomberg’s calculator provides a snapshot in time, designed to put today’s vaccination rates into perspective. It uses the most recent rolling average of vaccinations, which means that as vaccination numbers pick up, the time needed to hit the 75% threshold will fall.
The calculations will be volatile, especially in the early days of the rollout, and the numbers can be distorted by temporary disruptions.
For example, New York’s target date was pushed out to 17 months this week after a winter blizzard prevented some from getting vaccinated. Likewise, Canada’s vaccination rate dropped by half in recent weeks following reports of delayed vaccine shipments. Based on Canada’s latest rate of inoculations, it would take 9.7 years to reach 75% coverage. That might serve as a wake-up call to Canadian politicians and health officials, but it doesn’t mean they’re doomed to a decade of social distancing. Canada has contracts to buy more vaccine doses per person than any other country, and its vaccination rates are expected to climb.
The pace is likely to accelerate further as more vaccines become available. Some of the world’s biggest vaccine-manufacturing hubs in India and Mexico are only just getting started. More than 8.5 billion doses of vaccine have been contracted by countries through more than 100 agreements tracked by Bloomberg. Only a third of countries have even begun their vaccination campaigns.
Vaccinations protect against COVID-19 within a few weeks of getting the shots. But if just a few people in a community get vaccinated, the virus can continue to spread unchecked. As more people get the vaccine, groups of people start to build a collective defense against the virus so that isolated sparks of infection burn out instead of spreading into an outbreak. The concept is known as herd immunity.
In the scientific community, there are conflicting definitions for when herd immunity is achieved. Is it when enough people are protected that it begins to have a measurable effect on the speed of transmission? That could begin well before 75% of people are fully vaccinated. Others define it as the point when outbreaks can no longer be sustained. For example, even if there’s a cluster of measles cases in an unvaccinated community, herd immunity prevents it from rippling across a country.
The vaccines available today require two doses for full vaccination. Our calculations for coverage are based on two doses per person in the population but don’t distinguish between first doses or second doses administered. Those breakdowns can distort daily vaccination rates and aren’t available in more than 20% of the countries we’re tracking.
A new vaccine by Johnson & Johnson recently showed positive results using a single dose in a large clinical trial. If approved, we’ll adjust the number of doses required proportionate to its market share in each country.
The vaccines haven’t been authorized for use in children — those studies are currently under way. Our calculator, like the virus, includes children in the population needed to be protected.
One metric Bloomberg’s calculator doesn’t account for is any level of natural immunity that might result from recovering from COVID-19. It’s possible that hard-hit places might require a lower level of vaccination to prevent widespread transmission. While there’s evidence that people who recover from illness do retain some level of natural defenses, it’s unclear how much protection is offered or how long it might last. The vaccine is still recommended for people who have recovered from illness.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
Your news needs your support
Since the early stages of the COVID-19 crisis, The Japan Times has been providing free access to crucial news on the impact of the novel coronavirus as well as practical information about how to cope with the pandemic. Please consider subscribing today so we can continue offering you up-to-date, in-depth news about Japan.